(Q48112846)

English

Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

title

Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. (English)

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

main subject

sangivamycin

1 reference

stated in

ChEBI release 2020-05-28

Loomis CR

1

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

Bell RM

series ordinal

2

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

language of work or name

English

0 references

publication date

1 February 1988

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

published in

Journal of Biological Chemistry

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

volume

263

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

page(s)

1682-1692

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

issue

4

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

Identifiers

PubMed ID

3338987

1 reference

stated in

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/3338987

(Q48112846)

Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)